Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2018
Detection at Public Facilities of <sup>131</sup>I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for PatientsAthanasios Bikas, Di Wu, Evelyn Bethancourt, et al.
Endocrine|May 26, 2018
Use of <sup>99m</sup>Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical managementDi Wu, Dorina Ylli, Cristiane J Gomes Lima, et al.
Thyroid : Official Journal of the American Thyroid Association|February 11, 2010
Acute bacterial suppurative thyroiditis: a clinical review and expert opinionJohn E Paes, Kenneth D Burman, James Cohen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 23, 2016
Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid CancerAthanasios Bikas, Mark Schneider, Sameer Desale, et al.
Oral Diseases|September 1, 2018
Poor patient compliance with instructions for continuous sialogogues after <sup>131</sup> I therapyDi Wu, Gauri Khorjekar, Pejman Kharazi, et al.
American Journal of Surgery|December 4, 2022
Efficacy of machine learning to identify clinical factors influencing levothyroxine dosage after total thyroidectomyHui Zheng, Victoria Lai, Jana Lu, et al.
AJR. American Journal of Roentgenology|September 20, 2002
Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?Zsolt Szucs-Farkas, Judit Toth, Erzsebet Balazs, et al.
Journal of the American College of Surgeons|March 15, 2022
Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer Patients: A Multivariate AnalysisHui Zheng, Victoria Lai, Jana Lu, et al.
Thyroid : Official Journal of the American Thyroid Association|September 8, 2009
Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinomaDouglas Van Nostrand, Frank Atkins, Shari Moreau, et al.
Molecular Carcinogenesis|September 21, 2004
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cellsEri Miyagi, Milena Braga-Basaria, Elena Hardy, et al.
Pageof 13